NEO - NeoGenomics Inc logo

NEO

NeoGenomics Inc

NeoGenomics operates cancer-focused testing laboratories in the U.S. and U.K., providing diagnostic services like cytogenetics, molecular testing, flow cytometry, and more to hospitals, oncologists, and pharmaceutical companies, supporting cancer diagnosis and treatment.

โš•๏ธ Healthcare NASDAQ Listed 1999 $ USD
$1,000 invested 20 years ago โ†’$16,714today

Score Overview

1 Year
Score
Net Growth51.98%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth5.36%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score4.9
Net Growth-4x
Net Trend60%
Net Income Consistencyโ€”
Rev Growth58.22%
Rev TrendEvery year
Revenue Consistencyโ€”
10 Years
Score
Net Growth-6x
Net Trend60%
Net Income Consistency
Rev Growth213.95%
Rev Trend90%
Revenue Consistency
20 Years
Score4.2
Net Growth-397x
Net Trend50%
Net Income Consistency
Rev Growth118x
Rev Trend95%
Revenue Consistency
All Time
Score
Net Growth-51x
Net Trend50%
Net Income Consistency
Rev Growth3035x
Rev Trend92%
Revenue Consistency

See the full market ranking โ†’

NeoGenomics Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 444M to $ 727M and net income went from $ 4M to -$ 108M. Revenue increased in every one of those 5 years; net income in 3.

Across NeoGenomics Inc's full reported history, from 2000 to 2025, revenue grew from $ 252.4K to $ 727M and net income went from -$ 970K to -$ 108M. Revenue increased in 92% of the years measured; net income in 50%.

NeoGenomics Inc currently holds a 20-year HDB Score of 4.2 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 16.42โ€”
1 Year2025-08-12
$ 6.08170.07%
5 Years2021-08-12
$ 42.85-61.68%
10 Years2016-08-12
$ 7.96106.32%
20 Years2006-08-11
$ 0.9816x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 766M-$ 51M$ 145M
2025$ 727M-$ 108M$ 159M
2024$ 660M-$ 78M$ 386M
2023$ 591M-$ 87M$ 415M
2022$ 509M-$ 144M$ 437M
2021$ 484M-$ 8M$ 515M
2020$ 444M$ 4M$ 296M
2019$ 408M$ 8M$ 173M
2018$ 276M$ 2M$ 9M
2017$ 240M-$ 396K$ 12M
2016$ 244M-$ 6M$ 12M
2015$ 99M-$ 2M$ 23M
2014$ 87M$ 1M$ 33M
2013$ 66M$ 2M$ 4M
2012$ 59M$ 65K$ 1M
2011$ 43M-$ 1M$ 2M
2010$ 34M-$ 3M$ 1M
2009$ 29M-$ 2M$ 1M
2008$ 20M-$ 1M$ 468.17K
2007$ 11M-$ 3M$ 210.57K
2006$ 6M-$ 130K$ 126.27K
2005$ 1M-$ 997K$ 10.94K
2004$ 558.07K-$ 819K$ 112.55K
2003$ 369.97K-$ 536K$ 25.05K
2002$ 93.49K-$ 590.52K
2001$ 1K-$ 8M$ 77.22K
2000$ 252.4K-$ 970K$ 186.00

Explore beyond NEO

You're looking at NeoGenomics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies